LON:CYBG VanEck Bionic Engineering UCITS ETF A Acc (CYBG) Share Price, News & Analysis GBX 13.43 +0.01 (+0.04%) As of 04:42 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsBuy This Stock About VanEck Bionic Engineering UCITS ETF A Acc Stock (LON:CYBG) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get CYBG alerts:Sign Up Key Stats Today's Range 13.41▼ 13.5050-Day Range 12.43▼ 14.0452-Week Range 12.40▼ 16.50Volume96 shsAverage Volume1,122 shsMarket Capitalization£192.65 millionP/E RatioN/ADividend Yield2.25%Price TargetN/AConsensus RatingN/A Company Overview Providing investors access to opportunities that will strengthen their portfolios is VanEck’s guiding principle. Through forward-looking, intelligently designed active and ETF solutions, we offer value-added exposures to emerging industries, asset classes and markets as well as differentiated approaches to traditional strategies. We think beyond the financial markets to identify the trends—including economic, technological, political and social—that we believe will fuel investable opportunities. VanEck was one of the first U.S. asset managers to offer investors access to international markets and recognized early the transformative potential of gold investing, emerging markets and ETFs. Today, our firm’s capabilities range from core investment opportunities to more specialized exposures to enhance portfolio diversification. Read More Receive CYBG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for VanEck Bionic Engineering UCITS ETF A Acc and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CYBG Stock News HeadlinesVanEck Medical Robotics and Bionic Engineering UCITS ETFApril 16, 2026 | cnbc.comAxa Im Msci Em Mkts Eq Pab Ucits Etf A Share Price (AIQU.MI)November 4, 2024 | lse.co.ukA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live.July 15 at 1:00 AM | Porter & Company (Ad)VanEck UCITS ETFs Plc - Notice Convening an Extraordinary General Meeting of ShareholdersNovember 1, 2024 | finanznachrichten.deVanEck Bionic Engineering UCITS ETF (CYBO.L)May 17, 2024 | au.finance.yahoo.comVaneck Sustainable World Ew Ucits Etf Share ChatNovember 20, 2023 | lse.co.ukVanEck Global Mining UCITS A (GIGB)July 14, 2023 | uk.investing.comVanEck Genomics and Healthcare Innovators UCITS ETF (CURE)June 3, 2023 | uk.investing.comSee More Headlines CYBG Stock Analysis - Frequently Asked Questions How have CYBG shares performed this year? VanEck Bionic Engineering UCITS ETF A Acc's stock was trading at GBX 15.67 at the start of the year. Since then, CYBG stock has decreased by 14.3% and is now trading at GBX 13.43. How do I buy shares of VanEck Bionic Engineering UCITS ETF A Acc? Shares of CYBG stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of VanEck Bionic Engineering UCITS ETF A Acc own? Based on aggregate information from My MarketBeat watchlists, some other companies that VanEck Bionic Engineering UCITS ETF A Acc investors own include Virgin Money UK (VMUK), G-III Apparel Group (GIII), Alphabet (GOOG), Ionis Pharmaceuticals (IONS), Svenska Handelsbanken Ab Publ (SVNLY) and Western Union (WU). Industry, Sector and Symbol Stock ExchangeLON SectorFinance Industry Banks - Regional - Europe Sub-IndustryN/A Current SymbolLON:CYBG CIKN/A Webwww.cybg.com Phone+44-141-2324763FaxN/AEmployees5,762Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E Ratio0.00 P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales£1.24 billion Price / Sales0.16 Cash FlowGBX 100.45 per share Price / Cash Flow0.13 Book ValueGBX 355.10 per share Price / Book0.04Miscellaneous Outstanding Shares1,434,489,984Free FloatN/AMarket Cap£192.65 million OptionableNot Optionable BetaN/A The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (LON:CYBG) was last updated on 7/15/2026 by MarketBeat.com Staff. From Our PartnersTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredFrom the man who predicted 2008 crash…Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Bionic Engineering UCITS ETF A Acc Please log in to your account or sign up in order to add this asset to your watchlist. Share VanEck Bionic Engineering UCITS ETF A Acc With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
